5 berlin-brandenburg technology forum - vdgh · innovation strategy berlin-brandenburg at the tsb...

In vitro-Diagnostics and BioanalysisJune 5 – 6 · 2013 · Potsdam · GERMANY

Programme

5th BERLIN-BRANDENBURGTECHNOLOGY FORUM

Supported by:

Organized by:

In cooperation with:

5th Berlin-Brandenburg Technology Forum

In vitro-Diagnostics and Bioanalysis



Scientific LecturesThe latest trends in the deve-lopment of diagnostics

ExhibitionShowcasing products,services and technologies

PartneringPre-scheduled one-to-one meetings for companies and research institutes

Company Presentations Presentations by innovative diagnostics companies

Impressions



Your partner for next Generation in vitro-Diagnostics

Being the largest life sciences-spot, about 100 diag-nostics companies and a significant number of well-known research institutes cover the full range of the diagnostics value chain in the German Capital Region

– from biomarker identification to clinical research, production and services.

The Berlin-Brandenburg region develops solutions for next gene-

ration in vitro-diagnostics and bioanalysis, such as sensor-actor-

molecules and autonomous biosensors, genome, proteome- and

glycan-based multiplex analytics (microarray and bead technolo-

gies) and metabolomics platforms for new biomarker strategies.

Berlin-Brandenburg offers excellent conditions for implementing

clinical validation studies. Being Germany’s most diversified hos-

pital landscape with the Charité – Universitätsmedizin Berlin, it

has access to patient cohorts of urban and rural populations of

about 180 ethnicities, covering all medical indications. Custo-

mers from research and industry have access to advanced bioban-

king infrastructures.

June 5-6, 2013 · Potsdam 5th

Berlin-Brandenburg Technology Forum “In vitro-Diagnostics and Bioanalysis”

Facing the economical and medical challenges, new biomarkers and innovative diagnostics become more and more significant for the health care systems of the future. As basis for individualized therapy decisions, predictive testing is one of the key drivers for the next generation of in vitro-diagnostics.

For many years now, the Berlin-Brandenburg Technology Forum

on „In vitro-Diagnostics and Bioanalysis“ provides an excellent

platform for initiating a sustainable dialogue between fundamen-

tal research, industrial development and clinical application. The

5th Technology Forum focuses on mass spectrometry, protein ar-

rays and aptamer-based sensors.

A specially designed partnering event for diagnostics companies

and research institutes facilitates to meet new co-operation part-

ners from Europe and aims at fostering and encouraging possible

growth opportunities. Participants will have the opportunity to

join a guided science tour in Potsdam on June 5th.

This June, the Technology Forum 2013 will be once again the

place to be for discussing new trends and topics in the field of in

vitro-diagnostics.




In vitro-Diagnostics and Bioanalysis5th Berlin-Brandenburg Technology Forum


Programme

Wednesday, June 5

13:00—14:30 Workshop

Impact of the future IVD regulation on SMEs

in Europe—workshop with European experts

organized by EDCA”

(by separate invitation)

15:00—17:00 Guided Science Tour to Potsdam-Golm

Science Park

Leading international research from

biotechnology to gravitational physics, training for

young researchers and research-based production

combine to make this science park a location with

extraordinary potential for innovation, guided

tour of Fraunhofer Institute for Biomedical

Engineering IBMT included, tour starts at

conference venue.

15:00—17:30 EDCA Board Meeting

18:00—20:00 Welcome Reception

(by separate invitation)

Welcome Address

Kai Bindseil · Healthcare Industries Cluster

Manager Berlin-Brandenburg – HealthCapital

Biomarker strategy at Bayer AG

Ulrich Zügel · Bayer Pharma AG · Berlin · Germany

Life sciences in Canada: Changing paradigms

in diagnostics and treatment

Pierre Bélanger · Sherbrooke Innopole

Sherbrooke · Quebec

Programme

Thursday, June 6

Industrial Exhibition (9:00—17:00)About 25 SME showcase their latest products and

technologies

Partnering (9:00–17:00)

Welcome Addresses09:00 Günter Stock · Healthcare Industries Cluster

Spokesman Berlin-Brandenburg—HealthCapital

and President of the Berlin-Brandenburg Academy

of Sciences and Humanities (BBAW)

09:15 Basic research in Berlin-Brandenburg and

diagnostics development

Peter Seeberger · Max Planck Institute of Colloids and

Interfaces (MPIKG) · Berlin · Germany

09:30 Key Note

Mass spectrometry and its impact on next generation

diagnostics development

Matthias Mann · Max Planck Institute of Biochemistry

Martinsried · Germany

Session ITechnology DevelopmentChair: Frank Bier · Fraunhofer Insitute for Biomedical

Engineering (IBMT)

10:10 Targeted proteomics and imaging mass spectrometry

Edwin de Pauw · Liège University · Liège · Belgium

10:40 Coffee





11:00 DNA array to protein array technology (DAPA) for

applications in proteomics

Ronny Schmidt · Babraham Institute · Cambridge

United Kingdom

11:30 Design guidelines for the commercially successful

production of lab-on-a-chip consumables

Ralf Himmelreich · Institut für Mikrotechnik Mainz GmbH

Germany

12:00 The advantages of an aptamer based companion

diagnostic strategy

Gregory Penner · NeoVentures Biotechnology Inc.

London · Canada

12:30 Lunch

Session IIBiomarker and Clinical ResearchChair: Günter Peine · ZMDB

Rudolf Tauber · Charité – Universitätsmedizin Berlin

13:15 Mass cytometry based single cell analysis for

immunodiagnostics of the future

Andreas Thiel · BCRT/Charité Berlin · Germany

13:35 Metabolic biomarkers—an enabling new tool for the

development of drugs and diagnostics

Philipp Schatz · Metanomics Health GmbH · Berlin

Germany

13:55 Steroid analysis—clinical and research applications

Nils Krone · University of Birmingham · Birmingham

United Kingdom

14:25 Quantitative mass spectrometry of peptides and

proteins, a new era in clinical biomarker detection

Sylvain Lehmann · Universitaire de Montpellier

Montpellier · France

14:55 Identification of autoantibody biomarkers for colon

and prostate cancer screening assays using protein

microarrays

Johanna Fuchs-Luna · AIT Austrian Institute of Technology

GmbH · Vienna · Austria

15:25 Multiparametric protein detection in laboratory

medicine—technology and applications

Masood Kamali-Moghaddam · Science for Life Laboratory

Uppsala · Sweden

15:55 Expanding the quantitative targeted mass

spectrometry facility at the Necker-Enfants malades

University Hospital: The upcoming change in clinical

diagnosis

Sylvia Sanquer · Necker-Enfants malades University

Hospital · Paris · France

16:15 Coffee

Session IIIIndustrial Development—Medical ApplicationChair: Stefan von Senger und Etterlin · ZukunftsAgentur

Brandenburg

16:35 International Company Presentations

17:35 End of programme

Guided City Tour (18:00—19:30)

This tour presents the cultural heart of Potsdam-Sanssouci

palace and park, followed by dinner at an historical

location guided tour is free of charge, dinner is to be paid

individually.



Participation in the Technology Forum is free of charge.

The fee for the partnering event amounts € 50.00 (incl. VAT).

Prior registration is requested at

www.zmdb.de/technologyforum2013/

(Scientific Lectures and Guided Tours)

www.b2match.eu/tech-forum5/

(Partnering Event)

Your benefits from the Partnering Event:

k Showcase your profile to other participants of the event

k Organize yourself individual pre-scheduled one-to-one

meetings with the help of a web-based online tool

k Meet potential business, technological or research partners

for future co-operation

k Develop partnerships leading to technological and

commercial collaboration

k Establish cross-border contacts for long-term business

relationships

Whom you will meet:

k Developers and producers of in vitro-diagnostics

k Service providers

k Suppliers

k Distributors

k Research institutions

The earlier you submit your collaboration profile, the more it will be noticed.



The European Diagnostic Clusters Alliance unites around 400 diagnostic companies in 7 EU countries and is fully supporting the event, making it a real European quality brand for SME-directed diagnostic partnering.

EDCA unites the strengths of Europe’s diagnostics clusters for scientific excellence and economic growth!

Main Objectives » Facilitating the growth of European SMEs in medical diagnostics » Promoting cooperations between diagnostic clusters » Internationalizing of diagnostics development by European collaborative projects

Biocat Katalonien Barcelona ESBioWales Swansea GBBioWin Wallonia Liège BEEuromediag Languedoc-Roussillon Montpellier FRLife Science Cluster Krakau PLLyonbiopôle Lyon FRNexxus East of Scotland Edinburgh GBOxfordshire Bioscience Network Oxford GBUppsalaBio Uppsala SEZMDB/TSB Berlin-Brandenburg DE

Contact

TSB Innovationsagentur Berlin GmbH

Zentrum für Molekulare Diagnostik und Bioanalytik (ZMDB)

Dr. Günter Peine

[email protected]

www.zmdb.de

Venue

Schiffbauergasse · Schinkelhalle

14467 Potsdam · Germany

Directions: www.schiffbauergasse.de/index.php?b=3&p=55

(English version available)

Further Information

www.zmdb.de/technologyforum2013/

The Center for Molecular Diagnostics and Bioanalysis (ZMDB) is a Flagship Project of the Joint Innovation Strategy Berlin-Brandenburg at the TSB Innovationsagentur Berlin GmbH. The ZMDB is funded by the states of Berlin and Brandenburg and co-financed by the European Regional Development Fund (ERDF) of the European Union. An investment in your future!

5 berlin-brandenburg technology forum - vdgh · innovation strategy berlin-brandenburg at the tsb...

Documents